Research and Development of Neuroprotective Drugs Targeted for Glial Cells
Research and Development of Neuroprotective Drugs Targeted for Glial Cells
批准号:
13557222
负责人:
KOYAMA Yutaka
金额:
$5.31万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2001
资助国家:
日本
项目状态:
已结题
起止时间:
2001 至 2003
中文摘要
内皮素受体激动剂对培养的星形胶质细胞中神经营养因子产生的影响:损伤后神经系统的再生由星形胶质细胞产生的神经营养物质支持。在这项研究中,我们研究了内皮素-1(ET-1)的受体激动剂对星形胶质细胞产生神经营养因子的影响。ET-1刺激培养的星形胶质细胞表达胶质细胞源性神经营养因子(GDNF)和脑源性神经营养因子(BDNF)。脑室内注射ET受体激动剂可增加大鼠海马GDNF的mRNA和蛋白水平。ET激动剂还可增加尾壳核和大脑中BDNF的表达。培养的星形胶质细胞有外显子3和外显子4的BDNF转录,但没有外显子1和外显子2的转录。用ET-1处理增加了包含外显子3和外显子4的BDNF转录物。对ET诱导的星形胶质细胞BDNF基因转录的研究表明,DNF基因第3外显子的转录是由ERK和CREB介导的。第4外显子BDNF基因的表达受C/EBPβ介导的机制调控。这些结果提示ET受体可能是神经营养药物的作用靶点。新型神经营养药物T-588(一种具有神经保护作用的脐部药物)的作用机制是通过激活大鼠海马内的Erk来实现的。此外,我们还发现在动物模型中具有认知增强作用的FK 960刺激培养的大鼠星形胶质细胞产生GDNF。新型神经营养药物的这些作用可能是其药理作用的基础。
英文摘要
Effects of Endothelin Receptor Agonists on Neurotrophic Factor Production in cultured Astrocytes: Re-generation of nervous systems after injury is supported by neurotrophic substances produced by astrocytes. In this study, we examined effects of a receptor agonist of endothelin-1 (ET-1), which increased in damages brain, on neurotrophic factor production in astrocytes. ET-1 stimulated expressions of glial cell line-derived neurotrophic factor (GDNF) and brain-derived neurotrophic factor (BDNF) in cultured astrocytes. Intracerebroventircular administration of an ET receptor agonist Into rat brain increases both mRNA and protein levels of GDNF in hippocampus. BDNF expression in caudate putamen and cerebrum also increased by the ET agonist. Cultured astrocytes had exon 3 and exon 4-containing BDNF transcripts, but not exon 1 and exon 2 transcripts. Treatment with ET-1 increased both exon 3 and exon 4-containing BDNF transcripts. Examinations on ET-induced astrocytic BDNF transcription showed that the exon 3 of DNF gene were induced by ERK and CREB-mediated mechanisms. The exon 4 BDNF gene was shown to be mediated by C/EBPβ-mediated mechanisms. These results suggest that ET receptors are possible target of neurotrophic drugs.Mechanisms of novel neurotrophic drugs: T-588, a navel drug showing nouroprotective actions, caused Erk activation in rat hippocampus. Also, we found FK960, which have cognitive enhancing actions in animal models, stimulated GDNF production in rat cultured astrocytes. These actions of novel neurotrophic drugs may underlie their phsrmacological actions.
期刊论文(74)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Yokoyama I.: "T-588, a cognitive enhancer, stimulates in vivo phosphorylation of extracellular signal-regulated kinases in the hippocampus."Cogn.Brain Res.. 17. 522-525 (2003)
Yokoyama I.:“T-588 是一种认知增强剂,可刺激海马体内细胞外信号调节激酶的磷酸化。”Cogn.Brain Res.. 17. 522-525 (2003)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Ago Y.: "Regulation by 5-HT1A receptors of the in vivo release 5-HT and DA in mouse frontal cortex"Neuropharmacol.. 45. 1050-1056 (2003)
前 Y.:“小鼠额叶皮层体内 5-HT1A 受体释放 5-HT 和 DA 的调节”Neuropharmacol.. 45. 1050-1056 (2003)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Koyama Y.: "Focal adhesion kinase is required for endothelin-induced cell cycle progression of cultured astrocytes"Glia. 43. 185-189 (2003)
Koyama Y.:“内皮素诱导的培养星形胶质细胞的细胞周期进展需要粘着斑激酶”Glia。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
小山 豊: "脳傷害時のアストログリアの機能変化とその細胞内機構"日薬理誌. 119. 135-143 (2002)
Yutaka Koyama:“脑损伤期间星形胶质细胞的功能变化及其细胞内机制”日本药理学杂志 119. 135-143 (2002)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Matusda T.: "SEA0400, a novel and selective inhibitor of the Na^+-Ca^<2+> exchanger, attenuates reperfusion injury in the in vitro and in vivo cerebral ischemic models"J. Pharmacol. Exp. Ther.. 298. 249-256 (2001)
Matusda T.:“SEA0400,一种新型选择性Na^-Ca^2交换抑制剂,可减轻体外和体内脑缺血模型中的再灌注损伤”J.
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 27 条
Basic research for novel neurotrophic drugs targeting glial endothelin receptors
-
批准号:21590108
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.91万
-
财政年份:2009
-
负责人:KOYAMA Yutaka
-
依托单位:
Functional alteration of glial cells and brain edema formation
-
批准号:15590466
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.3万
-
财政年份:2003
-
负责人:KOYAMA Yutaka
-
依托单位:
Roles of endothelin receptors in astrocytic activation on brain pathologies
-
批准号:12670086
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.11万
-
财政年份:2000
-
负责人:KOYAMA Yutaka
-
依托单位:
国内基金
海外基金
缺血训练通过Astrocyte介导的HIF/Wnt信号转导通路促进脑缺血区域血管重塑的机制研究
-
批准号:82102666
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:梁丹
-
依托单位:
基于Microglia-Astrocyte级联反应研究电针阻滞腰椎间盘突出症急性疼痛向慢性疼痛转化的外泌体miRNA机制
-
批准号:82074529
-
项目类别:面上项目
-
资助金额:51.0万元
-
批准年份:2020
-
负责人:秦庆广
-
依托单位:
LCN2介导的M1型astrocyte在视网膜缺血/再灌注损伤后视功能障碍中的作用研究
-
批准号:81900890
-
项目类别:青年科学基金项目
-
资助金额:21.0万元
-
批准年份:2019
-
负责人:胡涂
-
依托单位: